Jane Street’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Sell
70,800
-4,000
-5% -$76.3K ﹤0.01% 5971
2025
Q4
$1.63M Buy
74,800
+57,100
+323% +$1.64M ﹤0.01% 5201
2025
Q3
$577K Sell
17,700
-3,800
-18% -$140K ﹤0.01% 7547
2025
Q2
$763K Sell
21,500
-18,700
-47% -$606K ﹤0.01% 6109
2025
Q1
$1.36M Sell
40,200
-9,400
-19% -$337K ﹤0.01% 5006
2024
Q4
$1.61M Buy
49,600
+30,600
+161% +$1.27M ﹤0.01% 4499
2024
Q3
$926K Buy
19,000
+1,200
+7% +$63.9K ﹤0.01% 6043
2024
Q2
$788K Sell
17,800
-93,500
-84% -$4.31M ﹤0.01% 6233
2024
Q1
$6.24M Buy
111,300
+71,700
+181% +$4.32M ﹤0.01% 2333
2023
Q4
$2.38M Sell
39,600
-1,600
-4% -$101K ﹤0.01% 4019
2023
Q3
$2.77M Buy
+41,200
New +$2.86M ﹤0.01% 3500
2023
Q2
Sell
-53,800
Closed -$2.59M 9189
2023
Q1
$2.59M Buy
53,800
+2,200
+4% +$108K ﹤0.01% 3389
2022
Q4
$2.58M Sell
51,600
-3,500
-6% -$170K ﹤0.01% 3453
2022
Q3
$2.25M Buy
55,100
+13,400
+32% +$629K ﹤0.01% 4006
2022
Q2
$2.29M Sell
41,700
-16,400
-28% -$693K ﹤0.01% 3902
2022
Q1
$2.11M Buy
58,100
+27,900
+92% +$1.1M ﹤0.01% 4660
2021
Q4
$1.41M Buy
+30,200
New +$1.53M ﹤0.01% 5226

Other funds holding LEGN

Jane Street's LEGN Position: Q1 2026 in Review

Jane Street sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 238,123 shares — an estimated $4.54M sold.

Jane Street first reported a position in LEGN in Q2 2020 and held it in 20 quarters. The position peaked at $5.18M in Q4 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Jane Street reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 238,123 Legend Biotech shares in Q1 2026, an estimated $4.54M.
  • Jane Street first reported a position in Legend Biotech in Q2 2020 and held it in 20 quarters.
  • Jane Street's Legend Biotech position peaked at $5.18M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.